(Q39524071)

12 September 2017

title

Differential expression of CDC25 phosphatases splice variants in human breast cancer cells (English)

1 reference

12 September 2017

6

Denyse Bagrel

0 references

author name string

Hélène Albert

1

1 reference

12 September 2017

Susana Santos

2

1 reference

12 September 2017

Eric Battaglia

3

1 reference

12 September 2017

Miguel Brito

4

1 reference

12 September 2017

Carolino Monteiro

5

1 reference

12 September 2017

publication date

16 June 2011

1 reference

Clinical Chemistry and Laboratory Medicine

12 September 2017

published in

1 reference

12 September 2017

volume

49

1 reference

12 September 2017

issue

10

1 reference

12 September 2017

page(s)

1707-1714

1 reference

Cell cycle, CDKs and cancer: a changing paradigm

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.635

CDC25 phosphatases in cancer cells: key players? Good targets?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.635

Cdc25: mechanisms of checkpoint inhibition and recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.635

p55CDC25 is a nuclear protein required for the initiation of mitosis in human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.635

The when and wheres of CDC25 phosphatases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.635

CDC25 phosphatases as potential human oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.635

Role of the Cdc25A phosphatase in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.635

Expression of cyclin-dependent kinases and CDC25a phosphatase is related with recurrences and survival in women with peri- and post-menopausal breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.635

Cell cycle dysregulation influences survival in high risk breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.635

Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.635

Cdc25 phosphatases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.635

Increased expression and activity of CDC25C phosphatase and an alternatively spliced variant in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.635

Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.635

Alternative splicing in the regulatory region of the human phosphatases CDC25A and CDC25C

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.635

Alternative splicing of the human CDC25B tyrosine phosphatase. Possible implications for growth control?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.635

Multiple splicing variants of cdc25B regulate G2/M progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.635

Cancer-associated regulation of alternative splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.635

Splice variants as cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.635

Over-expression of P-glycoprotein and glutathione S-transferase pi in MCF-7 cells selected for vincristine resistance in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.635

Analyzing real-time PCR data by the comparative C(T) method

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.635

Expression and functional significance of CDC25B in human pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.635

Aberrant pre-mRNA splicing of a highly conserved cell cycle regulator, CDC25C, in myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.635

Chk1 Kinase Negatively Regulates Mitotic Function of Cdc25A Phosphatase through 14-3-3 Binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.635

Differential mitotic degradation of the CDC25B phosphatase variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.635

A human cell line from a pleural effusion derived from a breast carcinoma

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/JNCI/51.5.1409

Breast tumor cell lines from pleural effusions

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/JNCI/53.3.661

Identifiers

DOI

10.1515/CCLM.2011.635

1 reference

release_xtrkhloqlzhh5d5tbjeihkglou

12 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xtrkhloqlzhh5d5tbjeihkglou

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference